Cargando…

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions

NLRC5 is a transcriptional regulator of MHC class I (MHCI), which maintains high MHCI expression particularly in T cells. Recent evidence highlights an important NK–T-cell crosstalk, raising the question on whether NLRC5 specifically modulates this interaction. Here we show that NK cells from Nlrc5-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludigs, Kristina, Jandus, Camilla, Utzschneider, Daniel T., Staehli, Francesco, Bessoles, Stéphanie, Dang, Anh Thu, Rota, Giorgia, Castro, Wilson, Zehn, Dietmar, Vivier, Eric, Held, Werner, Romero, Pedro, Guarda, Greta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749981/
https://www.ncbi.nlm.nih.gov/pubmed/26861112
http://dx.doi.org/10.1038/ncomms10554
_version_ 1782415353546014720
author Ludigs, Kristina
Jandus, Camilla
Utzschneider, Daniel T.
Staehli, Francesco
Bessoles, Stéphanie
Dang, Anh Thu
Rota, Giorgia
Castro, Wilson
Zehn, Dietmar
Vivier, Eric
Held, Werner
Romero, Pedro
Guarda, Greta
author_facet Ludigs, Kristina
Jandus, Camilla
Utzschneider, Daniel T.
Staehli, Francesco
Bessoles, Stéphanie
Dang, Anh Thu
Rota, Giorgia
Castro, Wilson
Zehn, Dietmar
Vivier, Eric
Held, Werner
Romero, Pedro
Guarda, Greta
author_sort Ludigs, Kristina
collection PubMed
description NLRC5 is a transcriptional regulator of MHC class I (MHCI), which maintains high MHCI expression particularly in T cells. Recent evidence highlights an important NK–T-cell crosstalk, raising the question on whether NLRC5 specifically modulates this interaction. Here we show that NK cells from Nlrc5-deficient mice exhibit moderate alterations in inhibitory receptor expression and responsiveness. Interestingly, NLRC5 expression in T cells is required to protect them from NK-cell-mediated elimination upon inflammation. Using T-cell-specific Nlrc5-deficient mice, we show that NK cells surprisingly break tolerance even towards ‘self' Nlrc5-deficient T cells under inflammatory conditions. Furthermore, during chronic LCMV infection, the total CD8(+) T-cell population is severely decreased in these mice, a phenotype reverted by NK-cell depletion. These findings strongly suggest that endogenous T cells with low MHCI expression become NK-cell targets, having thus important implications for T-cell responses in naturally or therapeutically induced inflammatory conditions.
format Online
Article
Text
id pubmed-4749981
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47499812016-03-04 NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions Ludigs, Kristina Jandus, Camilla Utzschneider, Daniel T. Staehli, Francesco Bessoles, Stéphanie Dang, Anh Thu Rota, Giorgia Castro, Wilson Zehn, Dietmar Vivier, Eric Held, Werner Romero, Pedro Guarda, Greta Nat Commun Article NLRC5 is a transcriptional regulator of MHC class I (MHCI), which maintains high MHCI expression particularly in T cells. Recent evidence highlights an important NK–T-cell crosstalk, raising the question on whether NLRC5 specifically modulates this interaction. Here we show that NK cells from Nlrc5-deficient mice exhibit moderate alterations in inhibitory receptor expression and responsiveness. Interestingly, NLRC5 expression in T cells is required to protect them from NK-cell-mediated elimination upon inflammation. Using T-cell-specific Nlrc5-deficient mice, we show that NK cells surprisingly break tolerance even towards ‘self' Nlrc5-deficient T cells under inflammatory conditions. Furthermore, during chronic LCMV infection, the total CD8(+) T-cell population is severely decreased in these mice, a phenotype reverted by NK-cell depletion. These findings strongly suggest that endogenous T cells with low MHCI expression become NK-cell targets, having thus important implications for T-cell responses in naturally or therapeutically induced inflammatory conditions. Nature Publishing Group 2016-02-10 /pmc/articles/PMC4749981/ /pubmed/26861112 http://dx.doi.org/10.1038/ncomms10554 Text en Copyright © 2016, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ludigs, Kristina
Jandus, Camilla
Utzschneider, Daniel T.
Staehli, Francesco
Bessoles, Stéphanie
Dang, Anh Thu
Rota, Giorgia
Castro, Wilson
Zehn, Dietmar
Vivier, Eric
Held, Werner
Romero, Pedro
Guarda, Greta
NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title_full NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title_fullStr NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title_full_unstemmed NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title_short NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions
title_sort nlrc5 shields t lymphocytes from nk-cell-mediated elimination under inflammatory conditions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749981/
https://www.ncbi.nlm.nih.gov/pubmed/26861112
http://dx.doi.org/10.1038/ncomms10554
work_keys_str_mv AT ludigskristina nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT janduscamilla nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT utzschneiderdanielt nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT staehlifrancesco nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT bessolesstephanie nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT danganhthu nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT rotagiorgia nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT castrowilson nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT zehndietmar nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT viviereric nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT heldwerner nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT romeropedro nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions
AT guardagreta nlrc5shieldstlymphocytesfromnkcellmediatedeliminationunderinflammatoryconditions